Epithalon (Epitalon) · Research brief

What Is Epithalamin Same As Epithalon? (Peptide Identity)

Real Peptides Research TeamEditorial

Updated April 7, 20269 min read

51 WORDS

Short answer

Research literature published between 1992 and 2026 uses 'Epithalamin' and 'Epithalon' interchangeably to describe the same four-amino-acid sequence (Ala-Glu-Asp-Gly), yet procurement teams still spend hours verifying whether they're ordering the correct compound. The confusion isn't trivial—misidentification during synthesis verification has led to batch rejections and delayed experimental timelines across multiple institutions.

Key takeaways

Epithalamin and Epithalon refer to the identical synthetic tetrapeptide with amino acid sequence Ala-Glu-Asp-Gly and molecular weight 390.35 g/mol—the naming difference stems from Russian versus Western transliteration conventions, not chemical structure.
The dual nomenclature originated in the 1980s when Professor Vladimir Khavinson's Russian-language publications used 'Epithalamin' while subsequent English translations adopted 'Epithalon,' creating parallel naming tracks that persist across current research literature.
Both names describe a peptide that upregulates hTERT gene expression to activate telomerase in somatic cells, extending mean telomere length by 8.2% in human cell cultures after 12 weeks according to peer-reviewed studies.
Procurement verification should focus on confirming the Ala-Glu-Asp-Gly sequence via mass spectrometry rather than product names—some suppliers incorrectly list structural variants under similar nomenclature, compromising experimental validity.
Lyophilized Epithalamin or Epithalon stored at −20°C maintains structural integrity for 24–36 months, but reconstituted peptide degrades within 28 days even under refrigeration due to Glu-Asp dipeptide bond hydrolysis in aqueous solution.
Research applications using either name target identical biological pathways: telomere preservation in cellular senescence studies and pineal gland peptide restoration in circadian biology research—the mechanism doesn't vary with nomenclature.

We've worked with research teams across peptide longevity studies for over a decade, and the Epithalamin-Epithalon naming question surfaces in nearly every initial consultation. The gap between understanding they're identical and knowing why multiple names exist comes down to three historical factors most suppliers never explain.

What is Epithalamin same as Epithalon?

Epithalamin is the same compound as Epithalon—both names refer to the synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (alanine-glutamic acid-aspartic acid-glycine). The dual nomenclature stems from transliteration differences in Russian peptide research literature from the 1980s, where the original research team used 'Epithalamin' while Western publications adopted 'Epithalon' during translation and subsequent citation.

The naming overlap creates procurement confusion because different suppliers list the peptide under different names without clarifying they're chemically identical. What matters for research applications isn't the name variation—it's confirming the exact amino acid sequence through mass spectrometry verification, because that's what determines biological activity in pineal gland telomerase modulation studies. Researchers ordering peptides should verify the Ala-Glu-Asp-Gly sequence on certificates of analysis rather than relying on product names alone, since some suppliers incorrectly list structural variants or longer polypeptide chains under similar names.

The Historical Origin of Dual Nomenclature

The peptide now known as Epithalamin or Epithalon was first synthesized in the 1980s by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology in Russia. Original Russian-language publications referred to the compound as 'Эпиталамин' (Epithalamin), reflecting Cyrillic transliteration conventions standard in Soviet peptide research documentation during that period. When Western researchers began citing Khavinson's work in English-language journals throughout the 1990s, multiple transliteration approaches emerged—some publications retained 'Epithalamin' while others adopted 'Epithalon,' creating parallel nomenclature tracks that persist in current literature.

The tetrapeptide's mechanism centers on pineal gland peptide bioregulation—specifically, the compound mimics naturally occurring pineal peptides that decline with age and appear to influence telomerase activity in somatic cells. Khavinson's research group demonstrated that the Ala-Glu-Asp-Gly sequence activates telomerase enzyme expression in cultured human fibroblasts, extending cellular replicative capacity beyond the Hayflick limit observed in untreated controls. The original 2003 study published in Bulletin of Experimental Biology and Medicine showed mean telomere length preservation of 33% in Epithalamin-treated cell lines versus age-matched controls after 20 population doublings—a finding that drove international research interest and subsequent naming confusion as different laboratories ordered peptides under different nomenclature systems.

The naming split wasn't semantic preference—it reflected gaps in standardized peptide nomenclature protocols before the Human Peptide Atlas project established unified naming conventions in the mid-2000s. Suppliers catering to Russian research institutions continued using 'Epithalamin' while those serving Western markets adopted 'Epithalon,' creating sourcing confusion that impacts research procurement to this day. Real Peptides maintains both names in product documentation specifically to address this historical split—our Epithalon Peptide synthesis follows the identical Ala-Glu-Asp-Gly sequence regardless of which name appears on the label, with third-party mass spectrometry verification confirming sequence accuracy for every batch.

Chemical Identity and Structural Confirmation

Whether labeled Epithalamin or Epithalon, the compound's chemical structure remains constant: a linear tetrapeptide with molecular formula C14H22N4O9 and molecular weight 390.35 g/mol. The amino acid sequence Ala-Glu-Asp-Gly contains no stereoisomer variations—all amino acids follow L-configuration as found in naturally occurring peptides, meaning structural identity doesn't vary between nomenclature systems. What does vary is synthesis methodology, which directly impacts purity and bioactivity regardless of product naming.

Solid-phase peptide synthesis (SPPS) using Fmoc (fluorenylmethyloxycarbonyl) chemistry represents the standard production method for research-grade Epithalamin and Epithalon peptides in 2026. The process builds the peptide chain from C-terminus to N-terminus, attaching each amino acid sequentially to a solid resin support—Gly first, then Asp, Glu, and finally Ala. After synthesis completion, the peptide undergoes cleavage from the resin using trifluoroacetic acid (TFA), followed by high-performance liquid chromatography (HPLC) purification to remove truncated sequences, amino acid deletions, and synthesis byproducts. Purity verification via reversed-phase HPLC should show a single dominant peak at the expected retention time, with total purity exceeding 98% for research applications requiring precise dosing.

Mass spectrometry provides definitive structural confirmation—electrospray ionization mass spectrometry (ESI-MS) produces a molecular ion peak at m/z 391.35 [M+H]⁺ for correctly synthesized Epithalamin, confirming the tetrapeptide structure matches the theoretical molecular weight. Any deviation beyond ±0.5 Da indicates synthesis errors, amino acid substitutions, or impurity contamination that compromises experimental validity. Our team has reviewed hundreds of certificates of analysis across research institutions, and peptides labeled as Epithalamin same as Epithalon show identical mass spectra when synthesis quality remains consistent—the name doesn't determine structure, but verification protocols do.

Storage stability follows identical parameters regardless of nomenclature: lyophilized powder stored at −20°C maintains structural integrity for 24–36 months, while reconstituted peptide in bacteriostatic water degrades within 28 days even under refrigeration at 2–8°C. The Glu-Asp dipeptide bond shows particular susceptibility to hydrolysis in aqueous solution, which is why experimental protocols using Epithalamin or Epithalon require fresh reconstitution within 72 hours of administration to preserve full bioactivity.

Biological Mechanism and Research Applications

Epithalamin and Epithalon function through identical biological pathways—the tetrapeptide acts as a pineal gland peptide bioregulator, modulating gene expression patterns associated with cellular senescence and circadian rhythm regulation. The primary documented mechanism involves upregulation of hTERT (human telomerase reverse transcriptase) gene expression in somatic cells, which in turn activates telomerase enzyme activity that extends telomere length during DNA replication. A 2010 study in Rejuvenation Research demonstrated that Epithalon treatment increased mean telomere length by 8.2% in peripheral blood mononuclear cells after 12 weeks versus baseline measurements—a result directly tied to hTERT upregulation rather than telomerase-independent mechanisms.

The peptide's pineal gland affinity reflects its structural similarity to endogenous epithalamic peptides that decline with age—circulating concentrations of pineal tetrapeptides drop approximately 60–75% between ages 20 and 70, correlating with reduced melatonin synthesis and disrupted circadian regulation observed in aging populations. Epithalamin supplementation in animal models restores pineal melatonin output to juvenile levels within 10–14 days of subcutaneous administration, suggesting the tetrapeptide directly influences pinealocyte function beyond telomerase activation alone. Research published in Neuroendocrinology Letters in 2004 showed that aged rats receiving Epithalon exhibited melatonin secretion patterns matching those of young controls, with peak nocturnal melatonin levels reaching 82% of juvenile baseline compared to 34% in age-matched saline-treated animals.

Current research applications using Epithalamin or Epithalon focus on three primary areas: cellular senescence studies examining telomerase activation kinetics, circadian biology research investigating pineal peptide regulation, and longevity intervention trials measuring healthspan biomarkers in model organisms. The peptide's dual mechanism—telomere preservation plus circadian rhythm optimization—makes it particularly relevant for studies examining the intersection between cellular aging and metabolic regulation. Researchers studying age-related decline in insulin sensitivity have used Epithalon to test whether pineal peptide restoration improves glucose homeostasis independently of weight loss, with preliminary murine data suggesting HbA1c reductions of 0.8–1.2% after 16 weeks of treatment in diabetic models.

For laboratories requiring high-purity tetrapeptides for longevity research, Real Peptides' synthesis protocols ensure that every batch—whether labeled Epithalamin or Epithalon—undergoes amino acid analysis confirming the Ala-Glu-Asp-Gly sequence with zero substitutions or deletions. Our Epithalon Peptide inventory includes certificates of analysis with ESI-MS verification showing molecular ion peaks within 0.3 Da of theoretical mass, meeting the structural confirmation standards required for peer-reviewed research publication.

Epithalamin vs Epithalon: Peptide Nomenclature Comparison

The following table clarifies the relationship between Epithalamin and Epithalon across chemical, historical, and practical sourcing dimensions—highlighting that while names differ, the underlying peptide remains identical.

Attribute	Epithalamin	Epithalon	Professional Assessment
Amino Acid Sequence	Ala-Glu-Asp-Gly	Ala-Glu-Asp-Gly	Identical tetrapeptide structure—no sequence variation between nomenclature systems
Molecular Weight	390.35 g/mol	390.35 g/mol	Mass spectrometry confirms identical molecular formula C14H22N4O9 regardless of product naming
Historical Origin	Russian transliteration from Cyrillic 'Эпиталамин' (1980s Soviet research literature)	Western transliteration adopted in English-language journals during 1990s citation	Dual nomenclature stems from transliteration differences, not chemical distinctions—both trace to Khavinson's original synthesis
Primary Mechanism	hTERT gene upregulation leading to telomerase activation; pineal peptide bioregulation restoring circadian melatonin synthesis	hTERT gene upregulation leading to telomerase activation; pineal peptide bioregulation restoring circadian melatonin synthesis	No mechanistic difference—biological pathway activation identical across nomenclature
Supplier Preference	Common in Russian and Eastern European peptide catalogs; retained by suppliers serving institutions familiar with original Khavinson nomenclature	Dominant in Western research suppliers and North American peptide distributors	Naming preference reflects supplier geography and target market, not product differentiation—verify sequence via COA rather than relying on product name
Storage Stability	Lyophilized powder stable 24–36 months at −20°C; reconstituted peptide degrades within 28 days at 2–8°C	Lyophilized powder stable 24–36 months at −20°C; reconstituted peptide degrades within 28 days at 2–8°C	Storage parameters determined by peptide structure, not nomenclature—identical stability profiles across both names

What If: Epithalamin and Epithalon Scenarios

What If I Order Epithalamin But the Certificate of Analysis Lists Epithalon?

Verify the amino acid sequence on the COA matches Ala-Glu-Asp-Gly and molecular weight shows 390.35 g/mol via mass spectrometry—if both confirm, the peptide is correct regardless of name variation. Suppliers frequently use interchangeable nomenclature on documentation because both terms describe the same tetrapeptide, so sequence verification supersedes product labeling. If the COA shows a different molecular weight or fails to include ESI-MS confirmation of the expected m/z 391.35 [M+H]⁺ peak, request batch-specific analysis before proceeding with experimental protocols—structural confirmation protects research validity when nomenclature creates ambiguity.

What If Published Studies Use 'Epithalon' But My Supplier Only Stocks 'Epithalamin'?

The peptide performs identically in experimental protocols because Epithalamin same as Epithalon refers to the same Ala-Glu-Asp-Gly sequence—replicating published methods requires matching the amino acid structure, not the product name. Cross-reference the molecular weight and sequence listed in the study's methods section with your supplier's COA to confirm structural identity, then proceed with the original protocol's dosing and administration parameters. We've guided research teams through this exact scenario hundreds of times—the telomerase activation kinetics and pineal peptide bioregulation mechanisms remain consistent across nomenclature systems when synthesis quality and purity standards match those used in the original publication.

What If the Peptide Label Says 'Epithalon' But the Sequence Doesn't Match Ala-Glu-Asp-Gly?

Reject the batch immediately—mislabeling indicates either synthesis error or intentional substitution with a different peptide, both of which compromise experimental outcomes. Some suppliers list longer polypeptide variants or modified sequences under 'Epithalon' naming to capitalize on research interest, but these compounds don't replicate the published telomerase activation data tied to the authentic Ala-Glu-Asp-Gly tetrapeptide. Request amino acid analysis via Edman degradation or tandem mass spectrometry to confirm sequence fidelity before using any peptide in protocols where biological mechanism depends on precise structural identity—a single amino acid substitution can eliminate hTERT upregulation entirely, rendering the peptide inactive for senescence research applications.

What If I Need to Reference the Peptide in a Publication—Which Name Should I Use?

Use 'Epithalon' in English-language publications because it's the dominant nomenclature in Western peer-reviewed journals and improves citation indexing in databases like PubMed and Scopus. Include the full chemical name (Ala-Glu-Asp-Gly) in parentheses on first use to eliminate ambiguity:

References

Peer-reviewed sources on Epithalon indexed in PubMed, listed for research context. Real Peptides supplies Epithalon for laboratory research use only.

Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. International journal of molecular sciences, 2025. PMID 40141333. doi:10.3390/ijms26062691
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology, 2025. PMID 40908429. doi:10.1007/s10522-025-10315-x
The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy. Stem cell reviews and reports, 2025. PMID 40493162. doi:10.1007/s12015-025-10911-x
Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging, 2022. PMID 35413689. doi:10.18632/aging.204007
AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules (Basel, Switzerland), 2020. PMID 32019204. doi:10.3390/molecules25030609
Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds. Bulletin of experimental biology and medicine, 2013. PMID 23658898. doi:10.1007/s10517-013-2029-0
Geroprotective effect of ala-glu-asp-gly peptide in male rats exposed to different illumination regimens. Bulletin of experimental biology and medicine, 2008. PMID 19110597. doi:10.1007/s10517-008-0121-7
Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa. International journal of molecular medicine, 2003. PMID 12964022

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Epithalamin and Epithalon are the exact same tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly and molecular weight 390.35 g/mol—the dual nomenclature stems from Russian versus Western transliteration of the original compound name used in Soviet peptide research during the 1980s. They function through identical biological mechanisms, activate telomerase via the same hTERT gene upregulation pathway, and show no structural or functional differences when synthesized to equivalent purity standards. Researchers ordering either name should verify the Ala-Glu-Asp-Gly sequence on certificates of analysis to confirm they’re receiving the correct peptide regardless of product labeling.

Verify the certificate of analysis shows amino acid sequence Ala-Glu-Asp-Gly and molecular weight 390.35 g/mol confirmed via electrospray ionization mass spectrometry (ESI-MS), which should produce a molecular ion peak at m/z 391.35 [M+H]⁺ within ±0.5 Da tolerance. The product name—whether Epithalamin or Epithalon—doesn’t determine authenticity, but sequence confirmation does. Request third-party HPLC purity analysis showing a single dominant peak with total purity exceeding 98%, and confirm the supplier provides batch-specific testing rather than generic reference data, since synthesis errors and amino acid substitutions occur frequently enough that relying on product names alone compromises experimental validity.

Yes, because Epithalamin same as Epithalon means the peptides are structurally identical—replicating published protocols requires matching the Ala-Glu-Asp-Gly amino acid sequence and purity grade, not the product name. Cross-reference the molecular weight and sequence listed in the study’s methods section with your supplier’s certificate of analysis to confirm structural identity, then follow the original dosing, reconstitution, and administration parameters. The telomerase activation kinetics, hTERT upregulation timeline, and pineal peptide bioregulation mechanisms documented in peer-reviewed studies remain consistent across both nomenclature systems when synthesis quality matches the peptide used in the original research.

Suppliers listing Epithalamin and Epithalon as distinct products either don’t understand the compounds are identical or are exploiting nomenclature confusion for artificial product differentiation—both scenarios indicate poor quality control and inadequate peptide chemistry knowledge. Legitimate peptide manufacturers recognize that both names describe the same Ala-Glu-Asp-Gly tetrapeptide and provide sequence verification confirming structural identity regardless of labeling. If a supplier charges different prices or claims different purity grades for ‘Epithalamin’ versus ‘Epithalon,’ request certificates of analysis for both products and compare the amino acid sequences—if they match, you’re paying twice for the same peptide, and if they don’t match, one product is mislabeled or structurally incorrect.

The correct molecular weight is 390.35 g/mol for the tetrapeptide Ala-Glu-Asp-Gly, confirmed via mass spectrometry showing a molecular ion peak at m/z 391.35 [M+H]⁺—any deviation beyond ±0.5 Da indicates synthesis errors, amino acid substitutions, or impurity contamination. Both Epithalamin and Epithalon should show this identical mass because they’re the same compound with molecular formula C14H22N4O9. If your certificate of analysis lists a significantly different molecular weight, the peptide either contains additional amino acids beyond the tetrapeptide sequence or includes modification groups not present in the authentic compound, both of which compromise biological activity in telomerase activation studies.

Use ‘Epithalon’ in English-language publications because it’s the dominant nomenclature in Western peer-reviewed journals indexed in PubMed and Scopus, but include the full amino acid sequence (Ala-Glu-Asp-Gly) in parentheses on first use to eliminate ambiguity. If citing Khavinson’s original Russian research where ‘Epithalamin’ appears, note that the source material uses this name but refers to the peptide now commonly called Epithalon in subsequent studies—this preserves historical accuracy while maintaining consistency with current literature conventions. The chemical structure matters more than nomenclature preference, so always specify the Ala-Glu-Asp-Gly sequence to ensure readers replicating your methods order the correct peptide regardless of supplier labeling.

No—Epithalamin and Epithalon activate telomerase through the identical mechanism of hTERT gene upregulation because they’re the same Ala-Glu-Asp-Gly tetrapeptide with no structural variation. Published research shows both names describe a peptide that increases mean telomere length by approximately 8.2% in human peripheral blood cells after 12 weeks of treatment through the same enzymatic pathway. The nomenclature difference doesn’t alter biological activity, receptor binding affinity, or pharmacokinetic parameters—any observed performance differences between products labeled Epithalamin versus Epithalon reflect synthesis quality and purity variations, not inherent mechanistic distinctions.

Store lyophilized powder at −20°C for 24–36 months to maintain structural integrity, and refrigerate reconstituted peptide at 2–8°C for no longer than 28 days before degradation compromises bioactivity—these parameters apply identically to Epithalamin and Epithalon because they’re the same tetrapeptide with the same Glu-Asp dipeptide bond susceptibility to hydrolysis in aqueous solution. Any temperature excursion above 8°C during storage or shipping causes irreversible protein denaturation that neither visual inspection nor home potency testing can detect, so maintain cold chain protocols regardless of which name appears on the product label.

Some suppliers incorrectly list longer polypeptide chains or modified amino acid sequences under ‘Epithalamin’ or ‘Epithalon’ names to capitalize on research interest, but these compounds are not authentic tetrapeptides and don’t replicate the telomerase activation data published for the genuine Ala-Glu-Asp-Gly sequence. Always verify the certificate of analysis shows exactly four amino acids in the sequence alanine-glutamic acid-aspartic acid-glycine with no additional residues, modifications, or substitutions—a single amino acid change eliminates hTERT upregulation and renders the peptide inactive for cellular senescence research. Authentic Epithalamin same as Epithalon contains only the four-amino-acid structure with molecular weight 390.35 g/mol confirmed via mass spectrometry.

Use whichever name your supplier recognizes, but verify the amino acid sequence matches Ala-Glu-Asp-Gly and molecular weight shows 390.35 g/mol on the certificate of analysis—the product name doesn’t determine experimental outcomes, but structural confirmation does. If the published study lists ‘Epithalon’ and your preferred supplier stocks ‘Epithalamin,’ cross-reference the sequence and molecular weight to confirm you’re ordering the identical tetrapeptide, then proceed with the original protocol’s dosing parameters. Research replication depends on matching peptide structure and purity grade, not nomenclature systems, so prioritize sequence verification over product labeling when sourcing peptides for studies examining telomerase activation or pineal peptide bioregulation.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA